Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis (1989)

Posted on by WOCredentials

“as THC has been shown to inhibit both clinical and histologic [experimental autoimmune encephalomyelitis], it may prove to be a new and relatively innocuous agent for the treatment of immune-mediated diseases.”

Lyman, W. D., Sonett, J. R., Brosnan, C. F., Elkin, R., & Bornstein, M. B. (1989). Δ9-Tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis. Journal of Neuroimmunology, 23(1), 73-81. DOI: 10.1016/0165-5728(89)90075-1

Read more…

Discover more from ContraReport

Subscribe to get the latest posts sent to your email.

Related Posts

A chronic low dose of THC restores cognitive function in old mice (2017)

“Here we show that a low dose of Δ9-tetrahydrocannabinol (THC) reversed the age-related decline in cognitive performance of mice aged 12 and 18 months. This behavioral effect was accompanied by […]

Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo-controlled study (2013)

“a short course (8 weeks) of THC-rich cannabis produced significant clinical, steroid-free benefits to 10 of 11 patients with active Crohn’s disease, compared with placebo, without side effects.” Naftali, T., […]

Cannabis-based medicine may cut seizures in half

“Taking cannabidiol may cut seizures in half for some children and adults with Lennox-Gastaut syndrome (LGS), a severe form of epilepsy” Discover more from ContraReport Subscribe to get the latest […]